布地奈德与复方异丙托溴铵雾化吸入用于毛细支气管炎治疗的临床效果
李桢,艾奎
(武汉市第三医院,湖北 武汉,430074)
浏览次数:129次 下载次数:407次
摘要:
目的 分析对毛细支气管炎采用布地奈德与复方异丙托溴铵联合雾化吸入治疗的效果。方法 选择2015年9月至2016年9月在本院接受治疗的毛细支气管炎患儿152例为研究对象,随机均分成对照组(76例)和观察组(76例),对照组患儿单 纯实施布地奈德雾化吸入治疗,观察组患儿选择布地奈德与复方异丙托溴铵雾化吸入结合治疗,比较两组患儿的治疗效果。结果 观察组患儿的临床治疗总有效率为97.37%,高于对照组的76.32%(P<0.05)。观察组患儿的呼吸急促缓解时间、喘憋缓 解时间、肺部哮鸣音消失时间、住院时间均短于对照组(P<0.05)。观察组血清PCT 水平为(0.42±0.14)ng/mL,CRP 水平为(0.50±0.10)mg/dL,均低于对照组的(0.53±0.22)ng/mL,(0.64±0.47)mg/dL(P<0.05)。结论 布地奈德与复方异丙托溴铵雾化吸 入联合用于治疗毛细支气管炎患儿效果明显,值得推广。
关键词:毛细支气管炎;布地奈德;复方异丙托溴铵;雾化吸入
中图分类号:R725.6文献标志码:A文章编号:2096-1413(2017)35-0044-02
Clinical effect of budesonide combined with compound ipratropium bromide in the treatment of capillary bronchitis
LI Zhen, AI Kui
(the Third Hospital of Wuhan, Wuhan 430074, China)
ABSTRACT: Objective To analyze the effect of budesonide combined with compound ipratropium bromide in the treatment of capillary bronchitis. Methods From September 2015 to September 2016, 152 patients with capillary bronchitis who were treated in our hospital were selected as the research objects, and were randomly divided into control group (76 cases) and observation group (76 cases). The control group only received budesonide inhalation, while the observation group accepted budesonide combined with compound ipratropium bromide. The treatment effects were compared in the two groups. Results The total effective rate in the observation group was 97.37%, which was higher than 76.32% of the control group (P<0.05). The relief time of shortness of breath, asthmatic relief, the disappearance time of lung wheeze, and the length of hospital stay in the observation group were shorter than those of the control group (P<0.05). The level of PCT in the observation group was (0.42±0.14) ng/mL and the CRP level was (0.50±0.10) mg/dL, which were lower than (0.53±0.22) ng/mL, (0.64±0.47)mg/dL in the control group respectively(P<0.05). Conclusion Budesonide combined with compound ipratropium bromide has obvious effect in the treatment of capillary bronchitis, which is worth promoting.
KEYWORDS: capillary bronchitis; budesonide; compound ipratropium bromide; inhalation
参考文献:
[1] 李静.布地奈德联合复方异丙托溴铵雾化吸入治疗小儿毛细支气 管炎疗效观察及其对血清PCT、hs-CRP 的影响[J].临床和实验医学杂志,2015,14(19):1641-1643.
[2] 欧有平.孟鲁斯特钠联合布地奈德和复方异丙托溴铵治疗婴幼儿 毛细支气管炎的疗效观察[J].现代药物与临床,2016,31(3):375-378.
[3] 刘鲜桂,周茵,彭露洁.布地奈德联合复方异丙托溴铵雾化吸入治 疗小儿毛细支气管炎疗效观察[J].中国保健营养(下旬刊),2013,23(2):861-862.
[4] 高峰泉.布地奈德混悬液联合复方异丙托溴铵溶液雾化吸入治疗 毛细支气管炎的效果分析[J].中国当代医药,2014,21(6):87-88.
[5] 刘东锋.复方异丙托溴铵联合布地奈德雾化吸入治疗小儿毛细支 气管炎的效果观察[J].临床医学研究与实践,2016,1(9):10,12.